JORDAN PRIEST: Open Payments
NPI 1790410751 · STEELVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 14 payments from 9 companies in 2025. Trend: 2023 $225 · 2024 $321 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| Inspire Medical Systems, Inc. | 1 | $92 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Pharmacosmos Therapeutics Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: INSPIRE, VRAYLAR, REXULTI, UBRELVY, MONOFERRIC, Ozempic, AIRSUPRA, FARXIGA.
Industry payments across MO — which companies pay providers there.
